S1P3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate

European Journal of Pharmacology

Volumn 469, Issue 1-3, 2003, Pages 125-134

  Salomone, Salvatore ^a,b   Yoshimura, Shin Ichi ^a   Reuter, Uwe ^a   Foley, Melissa ^a   Thomas, Sunu S ^a   Moskowitz, Michael A ^a   Waeber, Christian ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Cerebral vessel; S1P receptor; Sphingosine 1 phosphate; Suramin; Vasoconstriction

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ADENOVIRUS VECTOR; BACTERIAL TOXIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; PERTUSSIS TOXIN; RECEPTOR PROTEIN; RECEPTOR SUBTYPE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR 1; SPHINGOSINE 1 PHOSPHATE RECEPTOR 2; SPHINGOSINE 1 PHOSPHATE RECEPTOR 3; SPHINGOSINE 1 PHOSPHATE RECEPTOR 5; SURAMIN; UNCLASSIFIED DRUG; ANTISENSE OLIGONUCLEOTIDE; DRUG DERIVATIVE; G PROTEIN COUPLED RECEPTOR; LYSOPHOSPHOLIPID; LYSOPHOSPHOLIPID RECEPTOR; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE;

ADRENERGIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY TONE; ARTICLE; BLOOD CLOT; BRAIN ARTERY; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; CONTROLLED STUDY; DNA TRANSFER; DRUG INHIBITION; DRUG MECHANISM; DRUG SELECTIVITY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; THROMBOCYTE RELEASE REACTION; ANIMAL; C57BL MOUSE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; HUMAN; IN VITRO STUDY; PHYSIOLOGY; RABBIT; SPRAGUE DAWLEY RAT; VASOCONSTRICTION;

ANIMALS; CEREBRAL ARTERIES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LYSOPHOSPHOLIPIDS; MALE; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDES, ANTISENSE; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LYSOPHOSPHOLIPID; SPHINGOSINE; SURAMIN; VASOCONSTRICTION;

EID: 0038730511     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01731-X     Document Type: Article

References (41)

1. An S. Molecular identification and characterization of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate. Ann. N. Y. Acad. Sci. 905:2000;25-33.
2. Ancellin N., Hla T. Differential pharmacological properties and signal transduction of the sphingosine-1-phosphate receptors EDG-1, EDG-3, and EDG-5. J. Biol. Chem. 274:1999;18997-19002.
3. Bischoff A., Czyborra P., Fetscher C., Meyer Zu Heringdorf D., Jakobs K.H., Michel M.C. Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro. Br. J. Pharmacol. 130:2000;1871-1877.
4. Bischoff A., Czyborra P., Meyer Zu Heringdorf D., Jakobs K.H., Michel M.C. Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner. Br. J. Pharmacol. 130:2000;1878-1883.
5. Bogousslavsky J., Regli F. Unilateral watershed cerebral infarcts. Neurology. 36:1986;373-377.
6. Chun J., Goetzl E.J., Hla T., Igarashi Y., Lynch K.R., Moolenaar W., Pyne S., Tigyi G. International union of pharmacology: XXXIV. Lysophospholipid receptor nomenclature. Pharmacol. Rev. 54:2002;265-269.
7. Coussin F., Scott R.H., Wise A., Nixon G.F. Comparison of sphingosine 1-phosphate-induced intracellular signaling pathways in vascular smooth muscles: differential role in vasoconstriction. Circ. Res. 91:2002;151-157.
8. Dietrich W.D., Prado R., Pravia C., Zhao W., Ginsberg M.D., Watson B.D. Delayed hypovolemic hypotension exacerbates the hemodynamic and histopathologic consequences of thromboembolic stroke in rats. J. Cereb. Blood Flow Metab. 19:1999;918-926.
9. Ebersole B.J., Diglio C.A., Kaufman D.W., Berg K.A. 5-Hydroxytryptamine1-like receptors linked to increases in intracellular calcium concentration and inhibition of cyclic AMP accumulation in cultured vascular smooth muscle cells derived from bovine basilar artery. J. Pharmacol. Exp. Ther. 266:1993;692-699.
10. Eichholtz T., Jalink K., Fahrenfort I., Moolenaar W.H. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem. J. 291:1993;677-680.
11. English D., Welch Z., Kovala A.T., Harvey K., Volpert O.V., Brindley D.N., Garcia J.G. Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. FASEB J. 14:2000;2255-2265.
12. Goetzl E.J., An S. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. FASEB J. 12:1998;1589-1598.
13. Gohla A., Schultz G., Offermanns S. Role for G(12)/G(13) in agonist-induced vascular smooth muscle cell contraction. Circ. Res. 87:2000;221-227.
14. Gräler M.H., Bernhardt G., Lipp M. EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue. Genomics. 53:1998;164-169.
15. Hla T., Maciag T. An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. J. Biol. Chem. 265:1990;9308-9313.
16. Igarashi J., Michel T. Agonist-modulated targeting of the EDG-1 receptor to plasmalemmal caveolae. eNOS activation by sphingosine 1-phosphate and the role of caveolin-1 in sphingolipid signal transduction. J. Biol. Chem. 275:2000;32363-32370.
17. Igarashi J., Bernier S.G., Michel T. Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase. Differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells. J. Biol. Chem. 276:2001;12420-12426.
18. Im D.S., Heise C.E., Ancellin N., O'Dowd B.F., Shei G.J., Heavens R.P., Rigby M.R., Hla T., Mandala S., McAllister G., George S.R., Lynch K.R. Characterization of a novel sphingosine 1-phosphate receptor, Edg-8. J. Biol. Chem. 275:2000;14281-14286.
19. Kaiser J.R., Cox B.E., Roy T.A., Rosenfeld C.R. Differential development of umbilical and systemic arteries. I. ANG II receptor subtype expression. Am. J. Physiol. 274:1998;R797-R807.
20. Lee M.J., Thangada S., Claffey K.P., Ancellin N., Liu C.H., Kluk M., Volpi M., Sha'afi R.I., Hla T. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell. 99:1999;301-312.
21. Lynch K.R., Im D.S. Life on the edg. Trends Pharmacol. Sci. 20:1999;473-475.
22. Liu Y., Wada R., Yamashita T., Mi Y., Deng C.X., Hobson J.P., Rosenfeldt H.M., Nava V.E., Chae S.S., Lee M.J., Liu C.H., Hla T., Spiegel S., Proia R.L. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest. 106:2000;951-961.
23. Mittereder N., March K.L., Trapnell B.C. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 70:1996;7498-7509.
24. Mulvany M.J., Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res. 41:1977;19-26.
25. Murata N., Sato K., Kon J., Tomura H., Yanagita M., Kuwabara A., Ui M., Okajima F. Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem. J. 352:2000;809-815.
26. Murata N., Sato K., Kon J., Tomura H., Okajima F. Quantitative measurement of sphingosine 1-phosphate by radioreceptor-binding assay. Anal. Biochem. 282:2000;115-120.
27. Niedernberg A., Scherer C., Busch A., Kostenis E. Comparative analysis of human and rat S1P(5) (edg8): differential expression profiles and sensitivities to antagonists. Biochem. Pharmacol. 64:2002;1243-1250.
28. Okazaki H., Ishizaka N., Sakurai T., Kurokawa K., Goto K., Kumada M., Takuwa Y. Molecular cloning of a novel putative G protein-coupled receptor expressed in the cardiovascular system. Biochem. Biophys. Res. Commun. 190:1993;1104-1109.
29. Postma F.R., Jalink K., Hengeveld T., Moolenaar W.H. Sphingosine-1-phosphate rapidly induces Rho-dependent neurite retraction: action through a specific cell surface receptor. EMBO J. 15:1996;2388-2392.
30. Salomone S., Yoshimura S., Reuter U., Thomas S., Cutrer F.M., Waeber C. Selective cerebral vasoconstriction by sphingosine-1-phosphate: mechanism of action. Soc. Neurosci. Abstr. 646:2000;11.
31. Spitzbarth-Regrigny E., Petitcolin M.A., Bueb J.L., Tschirhart E.J., Atkinson J., Capdeville-Atkinson C. Pertussis toxin-sensitive G(i)-proteins and intracellular calcium sensitivity of vasoconstriction in the intact rat tail artery. Br. J. Pharmacol. 131:2000;1337-1344.
32. Tosaka M., Okajima F., Hashiba Y., Saito N., Nagano T., Watanabe T., Kimura T., Sasaki T. Sphingosine 1-phosphate contracts canine basilar arteries in vitro and in vivo: possible role in pathogenesis of cerebral vasospasm. Stroke. 32:2001;2913-2919.
33. Ullmer C., Schmuck K., Kalkman H.O., Lubbert H. Expression of serotonin receptor mRNAs in blood vessels. FEBS Lett. 370:1995;215-221.
34. Van Brocklyn J.R., Tu Z., Edsall L.C., Schmidt R.R., Spiegel S. Sphingosine 1-phosphate-induced cell rounding and neurite retraction are mediated by the G protein-coupled receptor H218. J. Biol. Chem. 274:1999;4626-4632.
35. Voogd T.E., Vansterkenburg E.L., Wilting J., Janssen L.H. Recent research on the biological activity of suramin. Pharmacol. Rev. 45:1993;177-203.
36. Wang F., Van Brocklyn J.R., Hobson J.P., Movafagh S., Zukowska-Grojec Z., Milstien S., Spiegel S. Sphingosine 1-phosphate stimulates cell migration through a Gi-coupled cell surface receptor. Potential involvement in angiogenesis. J. Biol. Chem. 274:1999;35343-35350.
37. Windh R.T., Lee M.J., Hla T., An S., Barr A.J., Manning D.R. Differential coupling of the sphingosine 1-phosphate receptors Edg-1, Edg-3, and H218/Edg-5 to the G(i), G(q), and G(12) families of heterotrimeric G proteins. J. Biol. Chem. 274:1999;27351-27358.
38. Xu Y., Zhu K., Hong G., Wu W., Baudhuin L.M., Xiao Y., Damron D.S. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1. Nat. Cell. Biol. 2:2000;261-267.
39. Yatomi Y., Ruan F., Hakomori S., Igarashi Y. Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood. 86:1995;193-202.
40. Yatomi Y., Igarashi Y., Yang L., Hisano N., Qi R., Asazuma N., Satoh K., Ozaki Y., Kume S. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J. Biochem. (Tokyo). 121:1997;969-973.
41. Zhu K., Baudhuin L.M., Hong G., Williams F.S., Cristina K.L., Kabarowski J.H., Witte O.N., Xu Y. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G Protein-coupled Receptor GPR4. J. Biol. Chem. 276:2001;41325-41335.